Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DEGS1 | O15121 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.33 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.31 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14541399 | 0.86 | AKT1 (0.38) | DEGS1KDM1AAKT1MEN1KMT2A | |
| SCHEMBL14851433 | 0.83 | AKT1 (0.35) | KDM1AAKT1MEN1KMT2ALMNA | |
| SCHEMBL3689955 | 0.81 | AKT1 (0.43) | DEGS1KDM1AAKT1SMN1; SMN2MEN1 | |
| SCHEMBL18173271 | 0.81 | AKT1 (0.43) | DEGS1KDM1AAKT1SMN1; SMN2MEN1 | |
| SCHEMBL1136742 | 0.81 | AKT1 (0.43) | DEGS1KDM1AAKT1SMN1; SMN2MEN1 | |
| SCHEMBL19308076 | 0.80 | GAA (0.33) | DEGS1AKT1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL26005397 | 0.80 | AKT1 (0.43) | AKT1MEN1KMT2ACES2CES1 | |
| SCHEMBL27478247 | 0.79 | AKT1 (0.41) | DEGS1KDM1AAKT1SMN1; SMN2MEN1 | |
| SCHEMBL23395187 | 0.79 | DEGS1 (0.43) | DEGS1KDM1ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL24922546 | 0.79 | DEGS1 (0.38) | DEGS1KDM1AAKT1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230380282-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-11-23 | — | — | US | disclosed |
| US-20230345755-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-10-26 | — | — | US | disclosed |
| US-20230225208-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
| US-20230150983-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225208-A1 | LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | CRY1, PER2, CRY2 | DEGS1 4665/4885KDM1A 3770/4885AKT1 4298/4885 |
| US-20230380282-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OCIAD2, AOX1 | DEGS1 3146/4885KDM1A 3308/4885AKT1 1348/4885 |
| US-20230150983-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | LAGE3, CRY1, CRY2 | DEGS1 4673/4885KDM1A 2736/4885AKT1 4579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.